NEW YORK (GenomeWeb) – KromaTid today announced it has selected Tebu-bio as its European distribution partner. 

Tebu-bio will distribute Fort Collins, Colo.-based KromaTid's genome imaging assays, which can determine DNA sequence, location, and orientation in a single test. KromaTiD's assays can detect genetic rearrangements, such as chromosomal inversions and translocations, that are missed by other diagnostic tools, the firm said in a statement. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.